Monalizumab
Names
[ CAS No. ]:
1228763-95-8
[ Name ]:
Monalizumab
Biological Activity
[Description]:
Monalizumab is a first-in-class immune checkpoint inhibitor targeting Natural Killer Group 2A (NKG2A). Monalizumab, a humanized anti-NKG2A blocking mAb, increases IFN-γ production, thereby promoting NK cell effector functions. Monalizumab can be used for the research of head and neck squamous cell carcinoma (HNSCC)[1][2].
[Related Catalog]:
[References]
Chemical & Physical Properties
No Any Chemical & Physical Properties